Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2003
06/11/2003CN1422859A Reaction method of biological alkali, reaction product and use thereof
06/11/2003CN1422849A 吲唑衍生物 Indazole derivative
06/11/2003CN1422659A Musk slow-controlled release preparation and preparation method thereof
06/11/2003CN1422658A Medicine for treating menalgia
06/11/2003CN1422652A Chinese medicinal preparation for treating gynaecology disease of cervicitis
06/11/2003CN1422647A Bone permeable blood-activating paste
06/11/2003CN1422639A Dral medicine for treating rheumatism and atrophic diseases
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide
06/10/2003US6576758 Nucleic acid constructs containing hybrid promoters
06/10/2003US6576745 Human cystatin F antibodies
06/10/2003US6576658 Compositions and uses of dictyostatin compounds
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576637 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations,
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576626 Treating gastro-oesophageal reflux disease
06/10/2003US6576613 Title inhibitors of urokinase
06/10/2003US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions
06/10/2003US6576271 Method for inhibiting inflammation using bioflavonoids
06/10/2003US6576260 Sustained-release form of administration containing tramadol saccharinate
06/10/2003CA2413024A1 Antipyretic preparation containing xylitol
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2054619C Aminocoumaran derivatives, their production and use
06/10/2003CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments
06/09/2003WO2003002536A1 Unsymmetrical cyclic diamine compound
06/06/2003WO2002044181A1 Hydantoin compounds useful as anti-inflammatory agents
06/06/2003CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003046580A1 Assay for screening candidate drugs for the treatment of inflammatory diseases
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046008A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045967A1 Aryl fused azapolycyclic compounds
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045942A2 Chemokine receptor antagonists and methods of use thereof
06/05/2003WO2003045941A1 Pyridine and pyrimidine derivatives
06/05/2003WO2003045938A1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045922A1 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
06/05/2003WO2003045917A2 Ccr-3 receptor antagonists vii
06/05/2003WO2003045896A1 New process
06/05/2003WO2003045582A1 Metallic structures incorporating bioactive materials and methods for creating the same
06/05/2003WO2003045456A1 Process for coating a surface of a stent
06/05/2003WO2003045416A2 Antiphlogistic agent and the use thereof
06/05/2003WO2003045411A2 Ginger extract preparation
06/05/2003WO2003045407A1 A pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof
06/05/2003WO2003045406A1 An chinese medicinal formulation treating stomachache, rib-side pain, headache and menstrual pain
06/05/2003WO2003045400A1 Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
06/05/2003WO2003045386A1 Benzothiazole derivatives
06/05/2003WO2003045384A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045383A1 Use of ppar activators for the treatment of pulmonary fibrosis
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
06/05/2003WO2003045373A1 Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
06/05/2003WO2003045369A2 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses
06/05/2003WO2003045360A2 Use of gaba for the treatment of intestinal inflammations
06/05/2003WO2003045338A1 Compositions comprising phenyl-glycine derivatives
06/05/2003WO2003045331A2 Formulations for oral administration of cromolyn sodium
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045317A2 Therapeutic protein and treatments
06/05/2003WO2003045316A2 Polynucleotide therapy
06/05/2003WO2003045228A2 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003WO2002074924A3 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
06/05/2003WO2002062841A3 Secreted proteins
06/05/2003WO2002060932A3 A serpin in bifidobacteria
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003US20030105333 RXR activating molecules
06/05/2003US20030105161 Analgesics; antiinflamamtory agents
06/05/2003US20030105159 Kavalactone compositions and methods of use
06/05/2003US20030105151 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases
06/05/2003US20030105150 Method of treating of demyelinating diseases or conditions
06/05/2003US20030105147 Analgesics, sedatives, anesthetics
06/05/2003US20030105144 Celecoxib dissolving in polyethylene glycol; antiinflammatory agents, osteoporosis, respiratory system disorders, antitumor agents, analgesics
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105141 Mixture containing fatty acid and aromatic amine; administering by mouth; cyclooxygenase enzyme inhibitor
06/05/2003US20030105123 For therapy of respiratory system disorders
06/05/2003US20030105118 Tricyclic quinazolinediones
06/05/2003US20030105113 Enantiomers of 1-[ (4-chlorophenyl) phenylmethyl ] -4-[ (4-methylphenyl) sulfonyl ] piperazine
06/05/2003US20030105112 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/05/2003US20030105110 Novel compounds
06/05/2003US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/05/2003US20030105095 4'-Methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105084 Compound which inhibit the release of inflammatory cytokines
06/05/2003US20030105075 Hymenialdisine or derivatives thereof in the manufacture of medicaments
06/05/2003US20030105069 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
06/05/2003US20030105052 Oligoribonucleotide derivatives for specific inhibition of gene expression
06/05/2003US20030105031 Administering therapeutically effective amount of one or more flavonoids and carrier for therapy of reactive and inflammatory dermatoses
06/05/2003US20030105027 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104977 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
06/05/2003US20030104976 Analgesic methods using endothelin receptor ligands
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104579 Pluripotent stem cells; antitumor agents; antiproliferative agents; antiinflammatory agents; veterinary medicine; tissue engineering
06/05/2003US20030104532 Neuroprotectants; angoigenesis inhibitors; transcription factors
06/05/2003US20030104482 Death associated kinase containing ankyrin repeats (DAKAR)
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104450 Novel regulator of g protein signalling
1 ... 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 ... 1272